Lung Cancer Surgery in the Elderly
Are you ever too old?

• Age itself is not a contraindication. In carefully selected patients in their 80s, the chance of cure from surgery is similar to that in younger patients.
• Fitness decides. Frailty, heart and lung reserve and general health determine who benefits. Even mild frailty raises risk, and it can be measured and often improved.
• Keyhole and lung-sparing surgery help older patients most. Robotic and VATS techniques, and smaller segmentectomy operations, reduce the strain of surgery and speed recovery.
• Surgery is not the only option. For some older patients, stereotactic (SABR) or conventional radiotherapy is the better choice, decided by the lung cancer multidisciplinary team.
• "Too old" deserves a second opinion. A decision made on age alone is different from a finding of unfitness on assessment, and a fresh assessment sometimes changes the answer.

There is no fixed age limit for lung cancer surgery. A diagnosis at 80, 82 or 85 does not, on its own, mean an operation is off the table, yet many older people and their families assume it does. That assumption costs lives, because for early-stage lung cancer surgery remains the treatment most likely to cure. The oldest patients Dr Okiror has operated on for lung cancer were 88: all five had a lobectomy and recovered well (personal operative data).

The most useful question on this page is “how fit are you?” Two people of the same age can be entirely different surgical propositions: one frail and burdened by other illness, the other active, independent and physiologically a decade younger. The assessment is of the patient’s physiology, and the rest of this page explains what it looks at, how surgery has been made safer for older patients, when radiotherapy is the better choice, and what to do if you or a relative has been told that age rules surgery out.

Studies of patients in their 80s undergoing surgery for early-stage lung cancer point consistently in the same direction: in carefully selected patients, five-year survival from the cancer itself is close to that of younger patients. The largest recent evidence is a prospective cohort from Mount Sinai in New York, published in 2026 (Yip et al., The Lancet Regional Health – Americas), of 884 patients who had surgery for stage IA lung cancer, 114 of them aged 80 or over. Five-year overall survival in the over-80s was 84%, against 87% in younger patients, and survival from the lung cancer itself was the same in both groups, at 94%.

Overall survival runs a little lower in older patients, and that largely reflects other illnesses competing for health in later life rather than the cancer or the operation. Complications, especially heart-related ones, are more common, which is why selection and preparation carry so much weight. The summary is encouraging but conditional: well-chosen older patients do well, and the work of choosing and preparing the right patients is what produces these results.

For most older patients, yes. Keyhole (VATS) and robotic surgery are carried out through a few small cuts rather than by opening the chest. That means less pain, a quicker return to mobility, a shorter hospital stay and fewer complications. These gains count most in older patients, who have the least reserve to spare. The change over the past decade has been substantial: operations that once meant a large incision and a hard recovery are now routinely done with minimal access.

Where it is safe to do so, a smaller lung-sparing operation, a segmentectomy that removes only the affected segment rather than a whole lobe, can clear the cancer while preserving more breathing capacity, which is particularly valuable for older patients with limited lung function. Dr Okiror performs more than eight in ten of his operations by keyhole or robotic techniques, and uses lung-sparing resections where appropriate, specifically to make surgery safer and recovery faster for older and higher-risk patients. The way an operation is done is itself one of the tools that makes age less of a barrier than it once was.

Surgery in later life is not risk-free. Complications are more common in older patients than younger ones. In the Mount Sinai cohort, 40% of patients aged 80 or over had a complication of some kind, most often a heart-related one such as an irregular rhythm, against 22% of younger patients. The first few months after the operation carry the greatest risk, and frailty raises it further.

These risks are discussed openly before any decision is made. They are also the reason the measures described on this page carry so much weight: careful selection, assessment and improvement of fitness, keyhole and robotic techniques, and a frank discussion of whether radiotherapy might be the safer route. The aim is to make sure that those who would benefit from surgery are not denied it, and that those who would not are steered to a better option.

Most patients go home within a few days of keyhole or robotic lung surgery. It is normal for both physical and mental wellbeing to dip in the first couple of months and then to recover. In the Mount Sinai cohort, quality of life fell at two months and had improved again by twelve months in both age groups, with no difference between patients over 80 and younger patients who had the same surgery.

Two things help older patients recover faster: enhanced recovery programmes, which get people moving, eating and home sooner after surgery, and prehabilitation beforehand, where patients who build up their fitness in advance tend to leave hospital earlier. Recovery takes effort, and the great majority of carefully selected older patients return to the life they had before the diagnosis. What happens between the clinic appointment and going home is set out on the admission and your stay page, and the weeks after discharge on the recovery after lung surgery page.

A second opinion is reasonable, and often valuable, for anyone told they cannot have lung cancer surgery on the grounds of age. A decision made on age alone is different from a finding of unfitness on assessment, and the threshold for “too high risk” varies between hospitals and between assessors. A fresh look at fitness, and where needed a period of optimisation or prehabilitation, sometimes moves a patient from inoperable to operable.

This is also a decision families are often closely involved in. Enquiries from a son or daughter on behalf of an older parent are welcome, and a clear assessment, which may confirm that a non-surgical option is the right one, is usually more reassuring than uncertainty. The purpose of a second opinion is to make sure the decision was made on fitness and the whole person rather than on age alone. How a lung cancer second opinion works, what to send and what it costs are on the lung cancer second opinion page.

Age is one of several reasons patients are given for not having an operation. The others, and which of them can change, are on the told surgery is not an option page. Who should judge fitness, and against which operation, is the subject of the Journal commentary Let me see him.

Disclosures and sources

This page is general patient information, not medical advice for any individual. Dr Lawrence Okiror is a Consultant Thoracic and Robotic Surgeon at Guy’s and St Thomas’ NHS Foundation Trust, with private practising privileges at London Bridge Hospital and The Lister Hospital Chelsea. Survival, complication and quality-of-life figures reflect carefully selected groups; individual risk and benefit vary and should be assessed in person. Decisions about treatment should be made with your own specialist team after appropriate assessment, and in many older patients a non-surgical option may be the most appropriate choice.

Sources: Yip R, Gros L, et al. Surgical outcomes and quality of life in octogenarians with early-stage non-small cell lung cancer: a prospective cohort study. The Lancet Regional Health – Americas 2026; doi 10.1016/j.lana.2026.101428. Swarbrick CJ, et al. Postoperative outcomes in older patients living with frailty and multimorbidity in the UK: SNAP-3, a snapshot observational study. British Journal of Anaesthesia 2025; doi 10.1016/j.bja.2025.04.026. Age-88 lobectomy outcomes and the keyhole/robotic proportion: personal operative data, 2024–25.